Value Added Medicines: Rethink, Reinvent & Optimise Medicines, Improving Patient Health & Access

31 May 2016

A new study Value Added Medicines: Rethink, Reinvent & Optimise […]

Value Added Medicines: Rethink, Reinvent & Optimise Medicines, Improving Patient Health & Access / 31 May 2016 17:30 – 19:30, European Parliament

4 May 2016

Medicines for Europe Reinforces its Commitment to Promote Universal Access to Health

19 April 2016

Over 100 participants will explore different ways and opportunities to […]

EGA becomes Medicines for Europe

10 March 2016

The European Generic and Biosimilar Medicines Association is now Medicines […]

Medicines for Europe: Better Access, Better Health

1 March 2016

EGA Prioritises Pursuing Sustainability Agreements

12 February 2016

Les génériques rament pour accéder au marché

7 October 2015

A Comprehensive And Fair Solution To The Price Of Medicines

7 October 2015

After a long dry spell, the pharmaceutical research industry has […]

Launch of European Value Added medicines (EVA), a new EGA sector group, will deliver efficiency

12 June 2015

Brussels – The European Generic and Biosimilar medicines Association (EGA) announced […]